Cell Analysis Market
Number of pages: 100 | Report Format: PDF | Published date: June 24, 2021
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023 to 2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 17.5 billion |
|
Revenue Forecast in 2031 |
US$ 40.59 billion |
|
CAGR |
9.8% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Product, Application, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global cell analysis market was valued at US$ 17.5 billion in 2022 and is expected to register a revenue CAGR of 9.8% to reach US$ 40.59 billion by 2031.
Cell Analysis Market Fundamentals
Cell analysis employs numerous techniques to examine the qualities and characteristics of cells, such as their size, shape, structure, functions, and behavior. This approach can give crucial insights into biological processes, disease causes, and therapeutic effectiveness. Flow cytometry, microscopy, cell culture, and molecular biology procedures are some techniques utilized for cell analysis. Cell analysis is important in many domains, including fundamental research, drug development, diagnostics, and customized treatment.
Additionally, cell analysis is the study of genetics, metabolomics, transcriptomics, and proteomics at the single-cell level. The single-cell analysis measures, analyzes, and sequences the human genome at the single-cell level. Fluorescence-activated cell sorting extracts single cells of interest from complicated samples. Cell analysis is planned to standardize and automate processes with vital information for real-time monitoring of cancer and, eventually, novel therapeutic options for the benefit of patients in clinical diagnostics. Cellular analysis is critical in gene identification, protein identification, epigenomics, and other aspects of life science. The improved precision of cell imaging and analysis technologies aids in the reduction of drug discovery time and cost. Cells are now evaluated in large numbers, with thousands of cells per sample, and findings are assessed based on the average response of the cells. As a result, to obtain useful and reliable cell analysis, it is necessary to examine how individual cells behave.
Flow cytometry (FCM) is a fast cellular analysis method initially designed to assess mammalian cells. Flow cytometry, as the name indicates, includes measuring cells floating in a flowing stream. This technique can collect information on cellular physiology, cell number, viability, genetic identity, and other parameters at the single-cell level across large populations. The ability of this technology to separate cells of interest from particulate matter that may be present in complicated samples is relevant to food (as well as environmental and clinical) microbiologists.
[653453434]
Cell Analysis Market Dynamics
Increased research activities, technological advancement, rising prevalence of chronic diseases, increased funding for life science research, growing demand for personalized medicines, advancements in stem cell research, and growing awareness of cell-based therapies are the key drivers influencing market expansion.
The global cancer burden, the growing biotech industry, and cell biology research are driving the growth of the cell analysis market. Cancer is one of the leading causes of mortality globally, accounting for almost one in every six deaths in 2020. The illness has spread dramatically over the last several decades and is projected to spread more in the next years. According to the National Cancer Institute, about 1,745,350 new cancer cases will be detected in the United States year 2020. Furthermore, the World Health Organization predicts that cancer deaths will increase by 70% globally over the next two decades. Single-cell DNA and RNA quantification technologies have piqued the interest of biotech research firms and universities. As a result, all these reasons raise the need for cell analysis during the forecast period.
Adaptation of flow cytometry in innovative research applications such as proteomics, marine cell biology, and cytogenetics has accelerated the development rate of the cell analysis industry. Furthermore, the increasing prevalence of HIV and cancer has increased the demand for flow cytometry techniques for accurate diagnostics in hospitals and laboratories. Furthermore, introducing reagents and multiple probes for diagnostics and drug discovery is expected to help the cause of cell analysis companies that target consumers in research/academic areas and small laboratories.
Furthermore, with the introduction of cell analysis applications in the oncology domain, the market is expected to grow unusually rapidly in the coming years. Cancer cell analysis includes researching tumor cell biology and developing cell-based treatments and medicines for cancer. Given these novel applications, investments in cancer research are increasing, with cell assay-based drug development gaining prominence and interest, amplifying demand for cell analysis instruments or technologies. According to the WCR Fund, worldwide cancer research funding is increasing at a 10% yearly pace, culminating in total spending of $177 billion on cancer research. The UNITED STATES federal government, Cancer Research U.K., and others are adding to this trend.
High content screening (HCS), a more complex cell analysis approach, has increased equipment costs. The targeted molecule's complexity directly influences the cost and duration of any HTS approach. As a result, innovative cell analysis solutions are only offered to a limited number of end users. For example, although universities and research institutions struggle to acquire such expensive gadgets due to financing restrictions, pharmaceutical, and biotech businesses lead the market. This restricts the market's growth by limiting the general use of cell analysis products. However, some obstacles are stifling the growth of the cell analysis market.
Cell Analysis Market Ecosystem
The global cell analysis is analyzed from the following perspectives by product, application, end user, and region.
Cell Analysis Market by Product
[8765453]
Based on the product, the global cell analysis market is segmented into consumables, instruments, and software. The consumables segment is further categorized into reagents, assay kits, and others (microplates, etc.). The instrument segment is further categorized into microscopes, flow cytometry, qPCR, high-content screening (HCS) systems, cell microarrays, spectrophotometers, and others (cell counters, next-generation sequencing, etc.).
The consumables segment dominates the market with the largest revenue share owing to frequent purchases and high usability of consumables such as reagents & assay kits, unlike instruments & software.
Cell Analysis Market by Application
Based on the applications, the global cell analysis market is segmented into cell identification, cell viability, cell signaling pathway/signal transduction, cell proliferation, cell counting & quality control, target identification & validation, single-cell analysis, and others (cell interaction, cell structure study, etc.).
The cell identification segment dominates the market with the largest revenue share. The cell identification process helps identify blood cells depending on their size, presence/absence of a nucleus in the cell, and shape of the nucleus. Furthermore, it also assists in identifying tumor cells with the help of spectroscopy and microfluidics. These factors are expected to drive the growth of the cell identification segment.
Cell Analysis Market by End User
Based on the end user, the global cell analysis market is segmented into hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies, academic and research institutes, and others (cell culture collection repositories, CROs, etc.).
The pharmaceutical & biotechnology companies segment is expected to be the fastest-growing end user segment during the forecast period. The segment's revenue growth can be attributed to growing drug research & development activities. Cell analysis instruments & consumables are widely used in various stages of drug discovery, pharmacokinetics, toxicology, and clinical studies.
Cell Analysis Market by Region
Based on region, the global cell analysis market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America dominates the cell analysis market with the largest revenue share, followed by Asia Pacific. The large revenue share of North America in the global market can be attributed to developed healthcare infrastructure, the rising prevalence of chronic diseases, growing R&D activities, and growing government initiatives. Furthermore, the presence of prominent players in the region and their continuous effort to launch technologically advanced cell analysis tools and instruments are also expected to boost the market's revenue growth. The expansion of biotechnological and biopharmaceutical firms is expected to provide chances in the cell analysis market. Strong R&D efforts and government funding for expediting development and advancements in cell analysis methodologies and tools have bolstered the business in recent decades. For example, companies and research organizations in these locations have been key actors in doing major research on stem cells and their application in treating life-threatening diseases such as multiple sclerosis and cancer.
Cell Analysis Competitive Landscape
Some of the prominent market players in the global cell analysis market include,
Cell Analysis Strategic Development
Cell analysis is the process of employing numerous techniques and technologies to examine the qualities and characteristics of cells, such as their size, shape, structure, functions, and behavior. This approach, among other things, can give crucial insights into biological processes, disease causes, and therapeutic effectiveness.
North America region is dominating the global cell analysis market.
Some key market players in the global cell analysis market include BD Biosciences, Danaher Corporation, and GE Healthcare.
The consumables segment led the global cell analysis market by product.
The revenue CAGR of the cell analysis market during the forecast period will be 9.8%
North America accounts for the largest revenue share of the global cell analysis market.
*Insights on financial performance are subject to the availability of information in the public domain